Joseph Clark
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Joseph Clark has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Himanshu Thapliyal
Electrical and Computer Engineering, Southern Methodist University, Dallas, TX, USA
2 shared publications Aigang Lu
Department of Neurology, Vontz Center for Molecular Studies, University of Cincinnati, Cincinnati, OH, USA
1 shared publication- Alexis B. Slutsky-Ganesh
Department of Kinesiology, University of North Carolina at Greensboro, 1408 Walker Avenue, Greensboro, NC, 27402, USA
1 shared publication - Brendan Leighton
Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden
1 shared publication - Christopher Andrew Dicesare
The SPORT Center, Division of Sports Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
1 shared publication Danielle Caudell
Department of Neurology Vontz Center for Molecular Studies, University of Cincinnati, Cincinnati, OH, USA
1 shared publication
Latest Publications
- Open Access
- 22 June 2026
- Published by Association for Computing Machinery (ACM)
- p. 650-657
SELSA: SDD-Based Efficient Logic Synthesis of Adiabatic Circuits
- 22 June 2026
- Published by Association for Computing Machinery (ACM)
- p. 650-657
Open AccessSELSA: SDD-Based Efficient Logic Synthesis of Adiabatic Circuits
- Open Access
- 5 June 2023
- Published by Association for Computing Machinery (ACM)
- p. 587-592
TDAG: Tree-based Directed Acyclic Graph Partitioning for Quantum Circuits
We propose the Tree-based Directed Acyclic Graph (TDAG) partitioning for quantum circuits, a novel quantum circuit partitioning method which partitions circuits by viewing them as a series of binary trees and selecting the tree containing the most gates. TDAG produces results of comparable quality (number of partitions) to an existing method called ScanPartitioner (an exhaustive search algorithm) with an 95% average reduction in execution time. Furthermore, TDAG improves compared to a faster partitioning method called QuickPartitioner by 38% in terms of quality of the results with minimal overhead in execution time.
- 5 June 2023
- Published by Association for Computing Machinery (ACM)
- p. 587-592
Open AccessTDAG: Tree-based Directed Acyclic Graph Partitioning for Quantum Circuits
We propose the Tree-based Directed Acyclic Graph (TDAG) partitioning for quantum circuits, a novel quantum circuit partitioning method which partitions circuits by viewing them as a series of binary trees and selecting the tree containing the most gates. TDAG produces results of comparable quality (number of partitions) to an existing method called ScanPartitioner (an exhaustive search algorithm) with an 95% average reduction in execution time. Furthermore, TDAG improves compared to a faster partitioning method called QuickPartitioner by 38% in terms of quality of the results with minimal overhead in execution time.
- 28 September 2021
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 49 (10) , 2863-2874
Evaluation of the Effectiveness of Newer Helmet Designs with Emergent Shell and Padding Technologies Versus Older Helmet Models for Preserving White Matter Following a Season of High School Football
We aimed to objectively compare the effects of wearing newer, higher-ranked football helmets (HRank) vs. wearing older, lower-ranked helmets (LRank) on pre- to post-season alterations to neuroimaging-derived metrics of athletes’ white matter. Fifty-four high-school athletes wore an HRank helmet, and 62 athletes wore an LRank helmet during their competitive football season and completed pre- and post-season diffusion tensor imaging (DTI). Longitudinal within- and between-group DTI metrics [fractional anisotropy (FA) and mean/axial/radial diffusivity (MD, AD, RD)] were analyzed using tract-based spatial statistics. The LRank helmet group exhibited significant pre- to post-season reductions in MD, AD, and RD, the HRank helmet group displayed significant pre- to post-season increases in FA, and both groups showed significant pre- to post-season increases in AD (p’s < .05 [corrected]). Between-group analyses revealed the pre- to post-season increase in AD was significantly less for athletes wearing HRank compared to LRank (p < .05 [corrected]). These data provide in vivo evidence that wearing an HRank helmet may be efficacious for preserving white matter from head impact exposure during high school football. Future prospective longitudinal investigations with complimentary imaging and behavioral outcomes are warranted to corroborate these initial in vivo findings.
- 28 September 2021
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 49 (10) , 2863-2874
Evaluation of the Effectiveness of Newer Helmet Designs with Emergent Shell and Padding Technologies Versus Older Helmet Models for Preserving White Matter Following a Season of High School Football
We aimed to objectively compare the effects of wearing newer, higher-ranked football helmets (HRank) vs. wearing older, lower-ranked helmets (LRank) on pre- to post-season alterations to neuroimaging-derived metrics of athletes’ white matter. Fifty-four high-school athletes wore an HRank helmet, and 62 athletes wore an LRank helmet during their competitive football season and completed pre- and post-season diffusion tensor imaging (DTI). Longitudinal within- and between-group DTI metrics [fractional anisotropy (FA) and mean/axial/radial diffusivity (MD, AD, RD)] were analyzed using tract-based spatial statistics. The LRank helmet group exhibited significant pre- to post-season reductions in MD, AD, and RD, the HRank helmet group displayed significant pre- to post-season increases in FA, and both groups showed significant pre- to post-season increases in AD (p’s < .05 [corrected]). Between-group analyses revealed the pre- to post-season increase in AD was significantly less for athletes wearing HRank compared to LRank (p < .05 [corrected]). These data provide in vivo evidence that wearing an HRank helmet may be efficacious for preserving white matter from head impact exposure during high school football. Future prospective longitudinal investigations with complimentary imaging and behavioral outcomes are warranted to corroborate these initial in vivo findings.
- 14 May 2019
- Published by Morressier GmbH
What Are the National Development Contexts in which Palliative Care Services Have (and Have Not) Developed? A Worldwide Ecological Study
Welcome to the largest platform for early-stage research
- 14 May 2019
- Published by Morressier GmbH
What Are the National Development Contexts in which Palliative Care Services Have (and Have Not) Developed? A Worldwide Ecological Study
Welcome to the largest platform for early-stage research
- 14 May 2019
- Published by Morressier GmbH
What Are the Opportunities for Cancer Care and Related Research in Primary Care? A Qualitative Study of the Views of Patients, Carers and Practice Staff
Welcome to the largest platform for early-stage research
- 14 May 2019
- Published by Morressier GmbH
What Are the Opportunities for Cancer Care and Related Research in Primary Care? A Qualitative Study of the Views of Patients, Carers and Practice Staff
Welcome to the largest platform for early-stage research
- 18 January 2011
- Published by IGI Global Scientific Publishing
The Allocation of Complexity in Economic Systems
The Allocation of Complexity in Economic Systems: 10.4018/978-1-59904-717-1.ch011: This chapter isolates a classic allocation problem in the substitution relation between two primary carriers of complex rules—agents and institutions—as a
- 18 January 2011
- Published by IGI Global Scientific Publishing
The Allocation of Complexity in Economic Systems
The Allocation of Complexity in Economic Systems: 10.4018/978-1-59904-717-1.ch011: This chapter isolates a classic allocation problem in the substitution relation between two primary carriers of complex rules—agents and institutions—as a
- 10 August 2010
- Published by Springer Nature in Translational Stroke Research
- Vol. 2 (1) , 17-25
Do Current Animal Models of Intracerebral Hemorrhage Mirror the Human Pathology?
Although intracerebral hemorrhage (ICH) has no proven treatment, well-designed studies using animal models of ICH may lead to the development of novel therapies. We briefly review current animal models of ICH. Furthermore, we discuss how these models may be utilized and targeted to facilitate translation of preclinical findings to the clinical arena.
- 10 August 2010
- Published by Springer Nature in Translational Stroke Research
- Vol. 2 (1) , 17-25
Do Current Animal Models of Intracerebral Hemorrhage Mirror the Human Pathology?
Although intracerebral hemorrhage (ICH) has no proven treatment, well-designed studies using animal models of ICH may lead to the development of novel therapies. We briefly review current animal models of ICH. Furthermore, we discuss how these models may be utilized and targeted to facilitate translation of preclinical findings to the clinical arena.
- 1 March 2009
- Published by Taylor & Francis in Neurological Research
- Vol. 31 (2) , 209-214
Hemorrhagic profile of the fibrinolytic alfimeprase after ischemia and reperfusion
Recanalization therapies for ischemic stroke have been slow to change clinical practice because of perceived and published risks of hemorrhage associated with lytic administration. We quantified alfimeprase in an acute ischemia-reperfusion model, as compared with recombinant tissue plasminogen activator, with hemorrhagic transformation as the primary endpoint and infarction volume and blood-brain barrier permeability as secondary endpoints. Five groups were studied in a blinded fashion: alfimeprase at doses of 0.03 (n=8), 0.1 (n=11) and 0.3 mg/kg (n=8); recombinant tissue plasminogen activator at 1 mg/kg (n=9); carrier infused controls (n=9). The middle cerebral artery was occluded for 5 hours followed by removal of the suture for reperfusion. Drugs were infused immediately following reperfusion over a 10-minute period. Approximately 24 hours later, the animals were anesthetized and decapitated, and the brains were rapidly harvested and frozen. Serial brain sections were obtained and inspected for hemorrhages. Infarction and blood-brain barrier permeability were also evaluated in additional experiments in control, 0.1 mg/kg alfimeprase and 1 mg/kg recombinant tissue plasminogen activator-treated rats. The hemorrhagic transformation frequency, neurological deficit and the mortality rate of alfimeprase were significantly lower than for recombinant tissue plasminogen activator at the 0.03 mg/kg dose and not statistically different at the higher doses. Infarction and blood-brain barrier permeability were not significantly different among control, 0.1 mg/kg alfimeprase and recombinant tissue plasminogen activator. In this model, alfimeprase, a new fibrinolytic agent, exhibits a profile comparable to recombinant tissue plasminogen activator.
- 1 March 2009
- Published by Taylor & Francis in Neurological Research
- Vol. 31 (2) , 209-214
Hemorrhagic profile of the fibrinolytic alfimeprase after ischemia and reperfusion
Recanalization therapies for ischemic stroke have been slow to change clinical practice because of perceived and published risks of hemorrhage associated with lytic administration. We quantified alfimeprase in an acute ischemia-reperfusion model, as compared with recombinant tissue plasminogen activator, with hemorrhagic transformation as the primary endpoint and infarction volume and blood-brain barrier permeability as secondary endpoints. Five groups were studied in a blinded fashion: alfimeprase at doses of 0.03 (n=8), 0.1 (n=11) and 0.3 mg/kg (n=8); recombinant tissue plasminogen activator at 1 mg/kg (n=9); carrier infused controls (n=9). The middle cerebral artery was occluded for 5 hours followed by removal of the suture for reperfusion. Drugs were infused immediately following reperfusion over a 10-minute period. Approximately 24 hours later, the animals were anesthetized and decapitated, and the brains were rapidly harvested and frozen. Serial brain sections were obtained and inspected for hemorrhages. Infarction and blood-brain barrier permeability were also evaluated in additional experiments in control, 0.1 mg/kg alfimeprase and 1 mg/kg recombinant tissue plasminogen activator-treated rats. The hemorrhagic transformation frequency, neurological deficit and the mortality rate of alfimeprase were significantly lower than for recombinant tissue plasminogen activator at the 0.03 mg/kg dose and not statistically different at the higher doses. Infarction and blood-brain barrier permeability were not significantly different among control, 0.1 mg/kg alfimeprase and recombinant tissue plasminogen activator. In this model, alfimeprase, a new fibrinolytic agent, exhibits a profile comparable to recombinant tissue plasminogen activator.
- 6 March 2008
- Published by Springer Nature in Analog Integrated Circuits and Signal Processing
- Vol. 56 (1-2) , 127-134
Development of an integrated hardware and software platform for the rapid detection of cerebral aneurysm rupture
- 6 March 2008
- Published by Springer Nature in Analog Integrated Circuits and Signal Processing
- Vol. 56 (1-2) , 127-134
Development of an integrated hardware and software platform for the rapid detection of cerebral aneurysm rupture
- Open Access
- 1 March 2008
- Published by Wiley in The FASEB Journal
- Vol. 22 (S1) , 1148.11
Role of Bilirubin Oxidation Products in delayed Cerebral Vasospasm after Subarachnoid Hemorrhage‐ an in vitro study
Delayed Cerebral Vasospasm (CV) is a crucial and often fatal complication of Subarachnoid hemorrhage (SAH). The etiology and molecular mechanism of CV is still a mystery. Recent reports have shown that Bilirubin Oxidation Products (BOXes) are present in significantly greater concentrations in the cerebrospinal fluid of patients with SAH who suffer from vasospasm (CSF V ) than in those who do not (CSF C ). Previous studies have shown that BOXes are vasoactive in vivo and potentiate smooth muscle contraction similar to PKC activators and phosphatase inhibitors in vitro. Using tissue bath apparatus, we examined the potentiation of phenylephrine (PE)‐induced force‐generation by various concentrations of BOXes in porcine carotid artery tissue rings. 1.5 – 7 μmol/L BOXes showed significantly increased potentiation of PE‐induced contraction when compared to vehicle. This was also observed with CSF V . We also studied the cytoplasm‐to‐membrane translocation of PKC's α and δ, and Rho in the presence of three different patho‐physiologically relevant concentrations of BOXes (0.2, 2 & 20μmol/L) at two‐points (20 minutes and 3 hours). Translocation of these proteins indicates their activation. Both PKC's and Rho were translocated in a time‐ and dose‐dependent manner by BOXes. Therefore, we postulate that BOXes may be one of the major molecules responsible for the etiology of CV after SAH.
- 1 March 2008
- Published by Wiley in The FASEB Journal
- Vol. 22 (S1) , 1148.11
Open AccessRole of Bilirubin Oxidation Products in delayed Cerebral Vasospasm after Subarachnoid Hemorrhage‐ an in vitro study
Delayed Cerebral Vasospasm (CV) is a crucial and often fatal complication of Subarachnoid hemorrhage (SAH). The etiology and molecular mechanism of CV is still a mystery. Recent reports have shown that Bilirubin Oxidation Products (BOXes) are present in significantly greater concentrations in the cerebrospinal fluid of patients with SAH who suffer from vasospasm (CSF V ) than in those who do not (CSF C ). Previous studies have shown that BOXes are vasoactive in vivo and potentiate smooth muscle contraction similar to PKC activators and phosphatase inhibitors in vitro. Using tissue bath apparatus, we examined the potentiation of phenylephrine (PE)‐induced force‐generation by various concentrations of BOXes in porcine carotid artery tissue rings. 1.5 – 7 μmol/L BOXes showed significantly increased potentiation of PE‐induced contraction when compared to vehicle. This was also observed with CSF V . We also studied the cytoplasm‐to‐membrane translocation of PKC's α and δ, and Rho in the presence of three different patho‐physiologically relevant concentrations of BOXes (0.2, 2 & 20μmol/L) at two‐points (20 minutes and 3 hours). Translocation of these proteins indicates their activation. Both PKC's and Rho were translocated in a time‐ and dose‐dependent manner by BOXes. Therefore, we postulate that BOXes may be one of the major molecules responsible for the etiology of CV after SAH.